mayo 02, 2023 1 lectura mínima

Want to know how we help? 

After years in the field, an international NGO supporting clinics in Tanzania, Uganda, Nigeria, and Haiti, had found that obstetric hemorrhage was one of the biggest preventable causes of maternal mortality. They were then looking to purchase the Non-Pneumatic Anti Shock Garment (NASG), a low-cost, evidence-based, first-aid device used to stabilize women experiencing obstetric hemorrhage. 

After a thorough search, they found Maternova offered the best path to acquiring the NASG. During discussions with our team, Maternova offered tailored advice on how to best pair the NASG with other low-cost, life-saving devices designed to prevent obstetric hemorrhage, like the CRADLE Vitals Monitor and the Obstetric Ballon. Based on the recommendations made by Maternova’s Chief Medical Officer, Dr. Luna Mehrain, they ordered the three products and incorporated them into their health programs and training sessions. To ease the introduction of the products into the work of their medical teams in Tanzania, Uganda, and Nigeria (50 professionals in total), Dr. Luna Mehrain offered a custom, live training on best practices for the three products.

This story is one of many where Maternova demonstrated a high level of medical expertise and efficiency to support its NGO clients. Paying close attention to medical innovations in this field, Maternova can offer tailored medical advice and products to your teams, supporting you in promoting maternal and neonatal health around the globe.

Dejar un comentario

Los comentarios se aprobarán antes de mostrarse.


Ver artículo completo

Benefits of intravenous iron to treat anemia in pregnancy
Benefits of intravenous iron to treat anemia in pregnancy

marzo 19, 2024 5 lectura mínima

Ver artículo completo
A Point of Care Bilirubinometer Using Blood: BiliDx
A Point of Care Bilirubinometer Using Blood: BiliDx

enero 16, 2024 2 lectura mínima

The BiliDx is a novel system for diagnosing jaundice.  The device uniquely meets the Target Product Profile (TPP) developed as part of the NEST 360 initiative in that it allows blood-based testing at the bedside.   This initiative is part of an emerging global consensus in the Every Newborn Action Plan that countries need functional WHO level-2 inpatient units to care for "small and sick newborns." 
Ver artículo completo
NASG as a life-saving medical device to stabilize women with postpartum hemorrhage
Consideraciones para el retiro del TANN

enero 15, 2024 2 lectura mínima

 El TANN debe ser retirado en un establecimiento donde sea posible el tratamiento definitivo en caso de re sangrado (capacidad quirúrgica, disponibilidad de hemoderivados etc.).
Ver artículo completo